Lenvatinib Mesylate Intermediate CAS 205448-65-3 Purity > 98.0% (HPLC) Hoobkas

Lus piav qhia luv luv:

Lub npe tshuaj: Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate

CAS: 205448-65-3 Nr

Purity:> 98.0% (HPLC)

Cov tsos mob: Tawm-dawb mus rau daj hmoov

Intermediate ntawm Lenvatinib Mesylate CAS 857890-39-2

E-Mail: alvin@ruifuchem.com


Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Chemical Properties:

Tshuaj npe Tom ntej: Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate
Synonyms 1,4-Dihydro-7-Methoxy-4-Oxo-6-Quinolinecarboxylic Acid Methyl Ester;7-Methoxy-4-Oxo-1,4-Dihydro-Quinoline-6-Carboxylic Acid Methyl Ester;Lenvatinib Intermediate 3
CAS Nr 205448-65-3
CAT Number RF-PI 1973
Tshuag xwm txheej Hauv Tshuag, Muaj Peev Xwm Ntau Lawm 50 MT / Xyoo
Molecular Formula C12H11NO4
Molecular Luj 233.22 Nws
Boiling Point 421.0 ± 45.0 ℃
Qhov ntom 1.267 ± 0.060g / cm3
Hom Ruifu Tshuaj

Specifications:

Yam khoom Specifications
Qhov tshwm sim Off-White to Yellowish Powder
Purity / Analysis Method > 98.0% (HPLC)
Poob rau ziab <1.00%
Residue ntawm Ignition <0.50%
Tag nrho cov impurities <2.00%
H-NMR Raws li tus qauv
Test Standard Enterprise Standard
Kev siv Pharmaceutical Intermediates

Pob & Cia:

Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo

Qhov zoo:

1

FAQ:

Daim ntawv thov:

Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate (CAS: 205448-65-3) yog ib qho nruab nrab ntawm Lenvatinib Mesylate (CAS: 857890-39-2).Lenvatinib, muag raws li lub npe Lenvima ntawm lwm tus, yog cov tshuaj tiv thaiv kab mob qog noj ntshav rau kev kho mob ntawm qee yam qog nqaij hlav qog noj ntshav thiab rau lwm yam mob qog noj ntshav.Nws tau tsim los ntawm Eisai Co. thiab ua raws li ntau yam kinase inhibitor tiv thaiv VEGFR1, VEGFR2 thiab VEGFR3 kinases.Lenvatinib tau txais kev pom zoo (txij li xyoo 2015) rau kev kho mob qog noj ntshav sib txawv uas yog nyob hauv zos rov tshwm sim lossis metastatic, kev loj hlob, thiab tsis teb rau kev kho mob nrog cov xov tooj cua iodine (radioiodine).Thaum lub Tsib Hlis 2016, US Food and Drug Administration (FDA) tau pom zoo nws (ua ke nrog everolimus) rau kev kho mob ntawm lub raum cell carcinoma tom qab ib qho kev kho mob angiogenic ua ntej.Cov tshuaj kuj tau pom zoo nyob rau hauv Teb Chaws Asmeskas thiab European Union rau hepatocellular carcinoma uas tsis tuaj yeem tshem tawm kev phais hauv cov neeg mob uas tsis tau txais kev kho mob qog noj ntshav los ntawm qhov ncauj lossis txhaj tshuaj.

Sau koj cov lus ntawm no thiab xa tuaj rau peb